BROOKSBSEBrooks Laboratories LtdMinimalNeutral
Announced Sat, 30 May · 12:31 IST

Newspaper Publication dated 30th May 2026 of Audited Financial Results for the quarter and year ended 31st March 2026.

BROOKS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.2%1-day move
₹65.29
prior close
₹68.55
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.8-1.5-0.0+0.0+3.2-0.4+0.9+0.8+2.6+4.5+7.2+10.7
Up moveDown movePending
AI summary

Brooks Laboratories Ltd published its audited standalone and consolidated financial results for Q4 FY2026 and the full year ended 31 March 2026, in Financial Express and Jansatta newspapers on 30 May 2026. For the full year FY2026, consolidated net profit grew to Rs 4.53 crore from Rs 3.54 crore in FY2025. Total consolidated revenue expanded to approximately Rs 192.3 crore from Rs 152.4 crore in the prior year. Q4 FY2026 net profit stood at Rs 1.97 crore. The company's board had approved these results on 29 May 2026. The consolidated entity operated approximately 250 retail stores, showing an expansion in retail presence. The results were published in compliance with SEBI Listing Regulations, with the statutory auditors having provided an unqualified audit opinion.

Likely market impact

The company delivered solid year-on-year profit and revenue growth for FY2026. The expansion of its retail store network alongside improving profitability signals operational strengthening. However, as this is a routine quarterly results publication, no major near-term share price catalyst is expected beyond market reaction to the published numbers.